What insurance policy changes affect CPT 69930?

There are 6 tracked policy changes affecting CPT 69930, including updates from Blue Cross Blue Shield of Rhode Island, Independence Blue Cross, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 69930?

Payers that have issued tracked updates for CPT 69930 include: Blue Cross Blue Shield of Rhode Island, Independence Blue Cross, Aetna.

How do I get notified when CPT 69930 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 69930. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 69930?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

69930 — A surgical procedure to place a hearing implant device directly into the inner ear to help restore sound perception.: Insurance Policy Changes

69930 Insurance Policy Changes

CPT 69930, in plain terms, covers A surgical procedure to place a hearing implant device directly into the inner ear to help restore sound perception. CPT 69930 is referenced in 6 tracked payer policy changes from Blue Cross Blue Shield of Rhode Island, Independence Blue Cross, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 69930 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

Electrocochleogram and Perilymphatic Pressure Measurement (CPB 0564, reviewed 2026-07-30)

Aetna·Effective Jul 30, 2026

Aetna updated its medical policy on electrocochleography (CPT 92584) to clarify coverage criteria. The procedure is now covered ONLY when used for: (1) evaluation of episodic dizziness/vertigo/tinnitus to rule out Meniere's disease or perilymphatic fistula, or (2) when performed with ABR testing in patients with profound hearing loss (PTA ≥90 dB HL). Multiple other indications—including pre-implantation counseling, routine screening, intraoperative use during cochlear implant surgery, and perilymphatic pressure measurement—are explicitly classified as experimental/investigational and NOT covered.

69930 Insurance Policy Changes

Medical policy updates

11.01.02s, Cochlear Implantation

Electrocochleogram and Perilymphatic Pressure Measurement (CPB 0564, reviewed 2026-07-30)

Tinnitus Treatments (CPB 0406, reviewed 2026-07-10)

11.01.02s, Cochlear Implantation

MA11.039e, Cochlear Implantation